These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 9818542)

  • 61. [Experimental models of systemic scleroderma].
    Serakovski S; Kukhazh E; Bernatska K
    Revmatologiia (Mosk); 1989; (3):36-46. PubMed ID: 2692123
    [No Abstract]   [Full Text] [Related]  

  • 62. [Extracorporeal photopheresis].
    Prinz B; Plewig G
    Hautarzt; 1994 Nov; 45(11):746-50. PubMed ID: 7822197
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Adhesion molecules in systemic scleroderma].
    Alekperov RT; Timchenko AV; Nasonov EL
    Ter Arkh; 2003; 75(5):91-5. PubMed ID: 12847909
    [No Abstract]   [Full Text] [Related]  

  • 64. The Dunlop-Dottridge Lecture. Longterm persistence of fetal and maternal cells: implications for systemic sclerosis and other autoimmune diseases.
    Nelson JL
    J Rheumatol; 2000 Dec; 27(12):2922-6. PubMed ID: 11128687
    [No Abstract]   [Full Text] [Related]  

  • 65. Identification of three different anti-4S RNA sera associated with autoimmune disease.
    Epstein P; Lidsky M; Reddy R; Tan E; Busch H
    Biochem Biophys Res Commun; 1982 Nov; 109(2):548-55. PubMed ID: 7181933
    [No Abstract]   [Full Text] [Related]  

  • 66. [Scleroderma].
    Dupond JL; Humbert P; Renaud A
    Soins; 1987 Dec; (507):21-2. PubMed ID: 2449734
    [No Abstract]   [Full Text] [Related]  

  • 67. [Immunologic similarities observed in the course of multiple sclerosis and systemic scleroderma].
    Czernicki J; Niedworok J; Onisk Z; Tchórzewski H
    Pol Tyg Lek; 1978 Feb; 33(9):337-40. PubMed ID: 652647
    [No Abstract]   [Full Text] [Related]  

  • 68. Cellular immune dysfunction and the pathogenesis of scleroderma.
    Jiménez SA
    Semin Arthritis Rheum; 1983 Aug; 13(1 Suppl 1):104-13. PubMed ID: 6353581
    [No Abstract]   [Full Text] [Related]  

  • 69. Critical roles of microRNAs in the pathogenesis of systemic sclerosis: New advances, challenges and potential directions.
    Miao CG; Xiong YY; Yu H; Zhang XL; Qin MS; Song TW; Du CL
    Int Immunopharmacol; 2015 Sep; 28(1):626-33. PubMed ID: 26241784
    [TBL] [Abstract][Full Text] [Related]  

  • 70. [Primary biliary cirrhosis and scleroderma: long-term benign course of a complex autoimmune disease].
    Pollak C; Minar E; Dragosics B; Marosi L
    Leber Magen Darm; 1985 Mar; 15(2):85-9. PubMed ID: 3990500
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [DNA-antibodies in patients with lupus erythematosus, scleroderma and blister-forming skin diseases].
    Kerl H; Sandhofer M; Klein G; Altmann H
    Hautarzt; 1975 Jan; 26(1):30-4. PubMed ID: 1090563
    [No Abstract]   [Full Text] [Related]  

  • 72. Effects of cytokine application on glucocorticoid secretion in an animal model for systemic scleroderma.
    Brezinschek HP; Gruschwitz M; Sgonc R; Moormann S; Herold M; Gershwin ME; Wick G
    J Autoimmun; 1993 Dec; 6(6):719-33. PubMed ID: 8155253
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Systemic Sclerosis Pathogenesis and Emerging Therapies, beyond the Fibroblast.
    Sierra-Sepúlveda A; Esquinca-González A; Benavides-Suárez SA; Sordo-Lima DE; Caballero-Islas AE; Cabral-Castañeda AR; Rodríguez-Reyna TS
    Biomed Res Int; 2019; 2019():4569826. PubMed ID: 30809542
    [TBL] [Abstract][Full Text] [Related]  

  • 74. New prospects for autoimmune disease therapy: B cells on deathwatch.
    St Clair EW; Tedder TF
    Arthritis Rheum; 2006 Jan; 54(1):1-9. PubMed ID: 16385491
    [No Abstract]   [Full Text] [Related]  

  • 75. [Anti-cardiolipin antibodies and other immunological disorders in patients with systemic scleroderma].
    Speranskiĭ AI; Riazantseva TA; Guseva NG; Melkumova KL; Ivanova SM
    Revmatologiia (Mosk); 1990; (3):11-4. PubMed ID: 2098888
    [TBL] [Abstract][Full Text] [Related]  

  • 76. [About "Multiple sclerosis and autoimmune diseases" ].
    Spadaro A; Valesini G
    Reumatismo; 2002; 54(1):68. PubMed ID: 12089618
    [No Abstract]   [Full Text] [Related]  

  • 77. Cell-mediated immunity in rheumatic disease.
    Padula SJ; Clark RB; Korn JH
    Hum Pathol; 1986 Mar; 17(3):254-63. PubMed ID: 3512415
    [TBL] [Abstract][Full Text] [Related]  

  • 78. NKT cells: potential targets for autoimmune disease therapy?
    Hammond KJ; Godfrey DI
    Tissue Antigens; 2002 May; 59(5):353-63. PubMed ID: 12144618
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Autoimmune and autoaggressive diseases].
    Spier HW
    Arch Klin Exp Dermatol; 1970; 237(1):18-26. PubMed ID: 5417105
    [No Abstract]   [Full Text] [Related]  

  • 80. Beneficial effects of antithymocyte globulin in severe cases of progressive systemic sclerosis.
    Tarkowski A; Lindgren I
    Transplant Proc; 1994 Dec; 26(6):3197-9. PubMed ID: 7998113
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.